Lang Ngo
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 10
- Epigenetics and DNA Methylation 8
- Protein Degradation and Inhibitors 3
- RNA Interference and Gene Delivery 2
- RNA modifications and cancer 2
- Ubiquitin and proteasome pathways 2
- Oncology top 5%
- Cancer-related Molecular Pathways 4
- Peptidase Inhibition and Analysis 2
- Hematology top 5%
- Physiology top 5%
- Geriatrics and Gerontology top 10%
- Co-authors
- Paul A. MarksP A MarksWeili XuVictoria M. RichonC. GuiMilos DokmanovicMegan L. ChoyWeisheng Xu
- Cited by
- Molecular BiologyOncologyHematology
- Journals
- Proceedings of the National Academy of Sciences (13 papers)The Journal of Infectious Diseases (1 paper)Gene (1 paper)
- Partner nations
- United StatesSwedenIsrael
In The Last Decade
Lang Ngo
19 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 2.2k
- Oncology 705
- Hematology 163
- Physiology 56
- Geriatrics and Gerontology 37
Countries citing papers authored by Lang Ngo
This map shows the geographic impact of Lang Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lang Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lang Ngo more than expected).
Fields of papers citing papers by Lang Ngo
This network shows the impact of papers produced by Lang Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lang Ngo. The network helps show where Lang Ngo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lang Ngo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 33 | |
| 2 | 2013 | 113 | |
| 3 | 2011 | 54 | |
| 4 | 2011 | 42 | |
| 5 | 2010 | 170 | |
| 6 | 2010 | 293 | |
| 7 | 2007 | 84 | |
| 8 | 2006 | 157 | |
| 9 | 2005 | 102 | |
| 10 | 2005 | 414 | |
| 11 | 2004 | 473 | |
| 12 | 1999 | 29 | |
| 13 | 1999 | 9 | |
| 14 | 1996 | 347 | |
| 15 | 1992 | 56 | |
| 16 | Changes in p34cdc2 kinase activity and cyclin A during induced differentiation of murine erythroleukemia cells. | 1992 | 17 |
| 17 | 1991 | 51 | |
| 18 | 1991 | 11 | |
| 19 | 1989 | 21 |
About Lang Ngo
Lang Ngo is a scholar working on Oncology, Molecular Biology, Health, Cellular and Molecular Neuroscience and Genetics, having authored 19 papers that have together received 2.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (10 papers), Epigenetics and DNA Methylation (8 papers), Cancer-related Molecular Pathways (4 papers), Protein Degradation and Inhibitors (3 papers), RNA Interference and Gene Delivery (2 papers), RNA modifications and cancer (2 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Molecular Biology (2.2k citations), Oncology (705 citations), Hematology (163 citations), Physiology (56 citations) and Geriatrics and Gerontology (37 citations). Lang Ngo has collaborated with scholars based in United States, Sweden and Israel. Frequent co-authors include Paul A. Marks, P A Marks, Weili Xu, Victoria M. Richon, C. Gui, Milos Dokmanovic, Megan L. Choy, Weisheng Xu, Ronald Breslow and Steven S. Foster. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Infectious Diseases, Gene, Molecular Cancer Therapeutics and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.